Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34451 | 111 | 16.7 | 33% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
| 34451 | 1 | TALNIFLUMATE//GUAR ACETATE//NEUROL NEUROL SURG ADJUNCT REHABIL MED | 111 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | TALNIFLUMATE | authKW | 2200764 | 7% | 100% | 8 |
| 2 | GUAR ACETATE | authKW | 275096 | 1% | 100% | 1 |
| 3 | NEUROL NEUROL SURG ADJUNCT REHABIL MED | address | 275096 | 1% | 100% | 1 |
| 4 | SEATTLE CONCUSS CLIN | address | 275096 | 1% | 100% | 1 |
| 5 | SUGARCANE PULP | authKW | 275096 | 1% | 100% | 1 |
| 6 | THIAPROPHENIC ACID | authKW | 275096 | 1% | 100% | 1 |
| 7 | NIFLUMIC ACID | authKW | 270273 | 12% | 8% | 13 |
| 8 | TERBIUM III ION | authKW | 137547 | 1% | 50% | 1 |
| 9 | MED HARBORVIEW MED | address | 91697 | 1% | 33% | 1 |
| 10 | IN VITRO DISSOLUTION TEST | authKW | 34385 | 1% | 13% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 625 | 44% | 0% | 49 |
| 2 | Rheumatology | 259 | 9% | 0% | 10 |
| 3 | Medicine, Research & Experimental | 167 | 15% | 0% | 17 |
| 4 | Medicine, General & Internal | 166 | 19% | 0% | 21 |
| 5 | Chemistry, Medicinal | 157 | 12% | 0% | 13 |
| 6 | Chemistry, Analytical | 91 | 14% | 0% | 15 |
| 7 | Biochemical Research Methods | 20 | 5% | 0% | 6 |
| 8 | Mathematical & Computational Biology | 7 | 2% | 0% | 2 |
| 9 | Biology | 5 | 3% | 0% | 3 |
| 10 | Chemistry, Organic | 4 | 5% | 0% | 5 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | NEUROL NEUROL SURG ADJUNCT REHABIL MED | 275096 | 1% | 100% | 1 |
| 2 | SEATTLE CONCUSS CLIN | 275096 | 1% | 100% | 1 |
| 3 | MED HARBORVIEW MED | 91697 | 1% | 33% | 1 |
| 4 | BOGATSKII PHYS CHEM | 30564 | 1% | 11% | 1 |
| 5 | BIO PROD | 17192 | 1% | 6% | 1 |
| 6 | EA 2962 | 10579 | 1% | 4% | 1 |
| 7 | BIOEQUIVALENCE BRIDGING STUDY | 9168 | 1% | 3% | 1 |
| 8 | PROGRAM BIOMED RADIAT SCI | 8334 | 1% | 3% | 1 |
| 9 | BOGATSKY PHYSICOCHEM | 7640 | 1% | 3% | 1 |
| 10 | AV BOGATSKY PHYSICOCHEM | 7141 | 2% | 1% | 2 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ORGANIC REACTIVITY | 26340 | 5% | 2% | 5 |
| 2 | CURRENT MEDICAL RESEARCH AND OPINION | 10447 | 12% | 0% | 13 |
| 3 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 6873 | 2% | 1% | 2 |
| 4 | SEMINARS IN ARTHRITIS AND RHEUMATISM | 3510 | 5% | 0% | 5 |
| 5 | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 3263 | 7% | 0% | 8 |
| 6 | PHARMACY INTERNATIONAL | 2197 | 2% | 0% | 2 |
| 7 | RHEUMATOLOGY AND REHABILITATION | 2114 | 1% | 1% | 1 |
| 8 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1396 | 5% | 0% | 6 |
| 9 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 914 | 4% | 0% | 4 |
| 10 | JOURNAL DE PHARMACIE DE BELGIQUE | 777 | 1% | 0% | 1 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TALNIFLUMATE | 2200764 | 7% | 100% | 8 | Search TALNIFLUMATE | Search TALNIFLUMATE |
| 2 | GUAR ACETATE | 275096 | 1% | 100% | 1 | Search GUAR+ACETATE | Search GUAR+ACETATE |
| 3 | SUGARCANE PULP | 275096 | 1% | 100% | 1 | Search SUGARCANE+PULP | Search SUGARCANE+PULP |
| 4 | THIAPROPHENIC ACID | 275096 | 1% | 100% | 1 | Search THIAPROPHENIC+ACID | Search THIAPROPHENIC+ACID |
| 5 | NIFLUMIC ACID | 270273 | 12% | 8% | 13 | Search NIFLUMIC+ACID | Search NIFLUMIC+ACID |
| 6 | TERBIUM III ION | 137547 | 1% | 50% | 1 | Search TERBIUM+III+ION | Search TERBIUM+III+ION |
| 7 | IN VITRO DISSOLUTION TEST | 34385 | 1% | 13% | 1 | Search IN+VITRO+DISSOLUTION+TEST | Search IN+VITRO+DISSOLUTION+TEST |
| 8 | MORNIFLUMATE | 34385 | 1% | 13% | 1 | Search MORNIFLUMATE | Search MORNIFLUMATE |
| 9 | EUROPIUMIII ION | 30564 | 1% | 11% | 1 | Search EUROPIUMIII+ION | Search EUROPIUMIII+ION |
| 10 | BIOEQUIVALENCE TEST | 27508 | 1% | 10% | 1 | Search BIOEQUIVALENCE+TEST | Search BIOEQUIVALENCE+TEST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | KIM, Y , YINN, SV , KIM, BH , LEE, S , (2017) PHARMACOKINETIC COMPARISON OF TWO FORMULATIONS OF TALNIFLUMATE 370 MG TABLETS IN HEALTHY KOREAN VOLUNTEERS.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 55. ISSUE 1. P. 102 -108 | 6 | 75% | 0 |
| 2 | PARK, EJ , NA, DH , SHIN, YH , LEE, KC , (2008) LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIC METHOD FOR THE SENSITIVE DETERMINATION OF NIFLUMIC ACID IN HUMAN PLASMA AND ITS APPLICATION TO PHARMACOKINETIC STUDY OF TALNIFLUMATE TABLET.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 876. ISSUE 2. P. 159-162 | 7 | 78% | 2 |
| 3 | PARK, EJ , SHIN, YH , LEE, KC , NA, DH , (2008) IMPROVED HPLC METHOD FOR THE DETERMINATION OF NIFLUMIC ACID IN HUMAN PLASMA AND ITS APPLICATION TO A BIOEQUIVALENCE STUDY OF TALNIFLUMATE TABLETS.BULLETIN OF THE KOREAN CHEMICAL SOCIETY. VOL. 29. ISSUE 4. P. 887-890 | 6 | 86% | 1 |
| 4 | CHO, HY , PARK, GK , LEE, YB , (2013) SIMULTANEOUS DETERMINATION OF MORNIFLUMATE AND ITS MAJOR ACTIVE METABOLITE, NIFLUMIC ACID, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY IN STABILITY AND PHARMACOKINETIC STUDIES.BIOMEDICAL CHROMATOGRAPHY. VOL. 27. ISSUE 11. P. 1438-1443 | 6 | 55% | 2 |
| 5 | BACON, P , LUQMANI, RA , BOSSINGHAM, DH , DAYMOND, TJ , GRAHAME, R , WEST, J , HAZLEMAN, BL , ADEBAJO, AO , HUGHES, GRV , ABDULLAH, M , ET AL (1990) A COMPARISON OF 2 FORMULATIONS OF INDOMETHACIN (FLEXIN CONTINUS TABLETS AND INDOCID CAPSULES) IN THE TREATMENT OF OSTEOARTHRITIS.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 12. ISSUE 2. P. 128-134 | 8 | 89% | 1 |
| 6 | YEH, KC , (1985) PHARMACOKINETIC OVERVIEW OF INDOMETHACIN AND SUSTAINED-RELEASE INDOMETHACIN.AMERICAN JOURNAL OF MEDICINE. VOL. 79. ISSUE 4C. P. 3-12 | 13 | 62% | 20 |
| 7 | WALLER, ES , (1983) EVALUATION OF NEW INDOMETHACIN DOSAGE FORMS.PHARMACOTHERAPY. VOL. 3. ISSUE 6. P. 324-333 | 13 | 72% | 10 |
| 8 | KANG, W , KIM, K , (2009) DETERMINATION OF TALNIFLUMATE AND NIFLUMIC ACID IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.ANALYTICAL SCIENCES. VOL. 25. ISSUE 4. P. 571-574 | 4 | 67% | 1 |
| 9 | ELSHATTAWY, H , KASSEM, A , OMAR, S , SAMI, A , YASSIN, AE , (1994) PREPARATION AND EVALUATION OF DIRECTLY-COMPRESSED INDOMETHACIN, INDOMETHACIN SODIUM AND INDOMETHACIN MEGLUMINE TABLETS.DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY. VOL. 20. ISSUE 5. P. 901-909 | 4 | 100% | 0 |
| 10 | GORDIN, A , SOTKA, S , NUUTILA, J , (1985) COMPARISON OF A SLOW-RELEASE INDOMETHACIN TABLET AND NAPROXEN IN OSTEOARTHROSIS.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 9. ISSUE 7. P. 500-504 | 6 | 100% | 3 |
Classes with closest relation at Level 1 |